GlobeNewswire 24/09/2015 Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatm...
GlobeNewswire 01/09/2015 Novartis receives EU approval for Tafinlar® and Mekinist®, first combination approved for patients w...
GlobeNewswire 24/07/2015 Novartis combination therapy Tafinlar® and Mekinist® achieves important EU and US regulatory milesto...
GlobeNewswire 01/06/2015 Novartis presents new data at ASCO for Zykadia® and combination of Tafinlar® and Mekinist® in certai...
GlobeNewswire 31/05/2015 Combination of Novartis drugs Tafinlar® and Mekinist® shows significant survival benefit in patients...
GlobeNewswire 05/09/2014 Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment f...
GlobeNewswire 24/07/2014 Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the America...
GlobeNewswire 18/06/2014 Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Admi...
GlobeNewswire 08/05/2014 Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results
GlobeNewswire 15/04/2014 Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Developm...
GlobeNewswire 09/04/2014 GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc.
GlobeNewswire 02/04/2014 Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex...
GlobeNewswire 17/03/2014 Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annua...
GlobeNewswire 10/03/2014 Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(T...
GlobeNewswire 18/02/2014 Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing
GlobeNewswire 10/02/2014 Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer
GlobeNewswire 21/01/2014 Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
GlobeNewswire 18/12/2013 Keryx Biopharmaceuticals Announces Issuance of U.S. Patent for Zerenex(TM) Covering Orally Administr...
GlobeNewswire 05/04/2007 Annual report & accounts